Shareholding disclosure

H.C. Wainwright & Co., LLC

Declared position

Threshold

Fell below threshold

Timeline

Published

16.01.2021

Transaction

11.01.2021

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAL1D00027

Beneficial owner

H.C. Wainwright & Co., LLC

Declared address

H.C. Wainwright & Co., LLC,, New York, NY 10022

Sale of shares by underwriter following closing of underwriting of capital increase

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

H.C. Wainwright & Co., LLC

Addex Therapeutics Ltd16.01.2021TAL1D00027

Disclosure summary

H.C. Wainwright & Co., LLC disclosed a holding in Addex Therapeutics Ltd that fell below the publication threshold, published by SIX Exchange Regulation on 16.01.2021, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

H.C. Wainwright & Co., LLC disclosed a holding in Addex Therapeutics Ltd, published on 16.01.2021.

Publication date16.01.2021

Transaction date11.01.2021

Issuing companyAddex Therapeutics Ltd

Beneficial ownerH.C. Wainwright & Co., LLC

Declared addressH.C. Wainwright & Co., LLC,, New York, NY 10022

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTAL1D00027

Conditions

Sale of shares by underwriter following closing of underwriting of capital increase

Source: SIX Exchange Regulation · Publication date: 16.01.2021

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open